Metabolic profiling reveals dysregulated lipid metabolism and potential biomarkers associated with the development and progression of Fragile X‐Associated Tremor/Ataxia Syndrome (FXTAS)-Reference-Cited by-同舟云学术

Metabolic profiling reveals dysregulated lipid metabolism and potential biomarkers associated with the development and progression of Fragile X‐Associated Tremor/Ataxia Syndrome (FXTAS)

Published:2020-11 Issue:12 Volume:34 Page:16676-16692
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Zafarullah Marwa¹,Palczewski Grzegorz²,Rivera Susan M.³⁴⁵,Hessl David R.⁵⁶,Tassone Flora¹⁵

Affiliation:

1. Department of Biochemistry and Molecular Medicine University of California Davis, School of Medicine Sacramento CA USA

2. Metabolon Morrisville NC USA

3. Center for Mind and Brain University of California Davis Davis CA USA

4. Department of Psychology University of California Davis Davis CA USA

5. MIND Institute, University of California Davis Medical Center Sacramento CA USA

6. Department of Psychiatry and Behavioral Sciences University of California Davis Medical Center Sacramento CA USA

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.202001880R

Reference67 articles.

1. Neurodegenerative diseases

2. Fragile X-associated tremor/ataxia syndrome — features, mechanisms and management

3. Fragile X syndrome

4. Penetrance of the Fragile X–Associated Tremor/Ataxia Syndrome in a Premutation Carrier Population

5. FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insight and Recommendations for Fragile X-Premutation-Associated Conditions from the Fifth International Conference on FMR1 Premutation;Cells;2023-09-21

2. Blood Proteome Profiling Reveals Biomarkers and Pathway Alterations in Fragile X PM at Risk for Developing FXTAS;International Journal of Molecular Sciences;2023-08-30

3. Brain Metabolomics in Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS);Cells;2023-08-23

4. Identification of three potential novel biomarkers for early diagnosis of acute ischemic stroke via plasma lipidomics;Metabolomics;2023-03-30

5. Plasma Quantitative Lipid Profiles: Identification of CarnitineC18:1-OH, CarnitineC18:2-OH and FFA (20:1) as Novel Biomarkers for Pre-warning and Prognosis in Acute Myocardial Infarction;Frontiers in Cardiovascular Medicine;2022-04-11